343 related articles for article (PubMed ID: 8466413)
1. The detection of problem analytes in a single proficiency test challenge in the absence of the Health Care Financing Administration rule violations.
Cembrowski GS; Hackney JR; Carey N
Arch Pathol Lab Med; 1993 Apr; 117(4):437-43. PubMed ID: 8466413
[TBL] [Abstract][Full Text] [Related]
2. Achieving the Health Care Financing Administration limits by quality improvement and quality control. A real-world example.
Engebretson MJ; Cembrowski GS
Arch Pathol Lab Med; 1992 Jul; 116(7):781-7. PubMed ID: 1497454
[TBL] [Abstract][Full Text] [Related]
3. Matrix effects on proficiency testing materials. Impact on accuracy of cholesterol measurement in laboratories in the nation's largest hospital system.
Naito HK; Kwak YS; Hartfiel JL; Park JK; Travers EM; Myers GL; Ross JW; Eckfeldt JH; Hartmann AE
Arch Pathol Lab Med; 1993 Apr; 117(4):345-51. PubMed ID: 8466396
[TBL] [Abstract][Full Text] [Related]
4. The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods.
Ross JW; Miller WG; Myers GL; Praestgaard J
Arch Pathol Lab Med; 1998 Jul; 122(7):587-608. PubMed ID: 9674541
[TBL] [Abstract][Full Text] [Related]
5. Health Care Financing Administration's new proficiency testing rules. Use of a statistical approach to predict long-term performance using the categories 'successful,' 'probation,' and 'suspended'.
Laessig RH; Ehrmeyer SS; Leinweber JE
Arch Pathol Lab Med; 1992 Jul; 116(7):770-6. PubMed ID: 1497452
[TBL] [Abstract][Full Text] [Related]
6. Clinical laboratory performance on proficiency testing samples--United States, 1994.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Mar; 45(9):193-6. PubMed ID: 8604217
[TBL] [Abstract][Full Text] [Related]
7. Reasons for proficiency testing failures in clinical chemistry and blood gas analysis: a College of American Pathologists Q-Probes study in 665 laboratories.
Steindel SJ; Howanitz PJ; Renner SW;
Arch Pathol Lab Med; 1996 Dec; 120(12):1094-101. PubMed ID: 15456173
[TBL] [Abstract][Full Text] [Related]
8. Accuracy verification and identification of matrix effects. The College of American Pathologists' Protocol.
Eckfeldt JH; Copeland KR
Arch Pathol Lab Med; 1993 Apr; 117(4):381-6. PubMed ID: 8466401
[TBL] [Abstract][Full Text] [Related]
9. Internal quality control, proficiency testing, and the clinical relevance of laboratory testing.
Kafka MT
Arch Pathol Lab Med; 1988 Apr; 112(4):449-53. PubMed ID: 3355347
[TBL] [Abstract][Full Text] [Related]
10. The quality assurance system in clinical chemistry.
Albertini A; Signorini C
Ann Ist Super Sanita; 1995; 31(1):3-8. PubMed ID: 8546372
[TBL] [Abstract][Full Text] [Related]
11. Statistical power in the detection of matrix effects.
Long T
Arch Pathol Lab Med; 1993 Apr; 117(4):387-92. PubMed ID: 8466402
[TBL] [Abstract][Full Text] [Related]
12. The stability of survey-assigned assay values when surveyed control materials are used in a daily interlaboratory quality control program. The College of American Pathologists Chemistry Survey--Quality Assurance Service shared pool experience.
Lawson PL; Lawson NS; Ross JW
Arch Pathol Lab Med; 1995 Apr; 119(4):312-33. PubMed ID: 7726725
[TBL] [Abstract][Full Text] [Related]
13. Medicare, Medicaid and CLIA programs; extension of certain effective dates for clinical laboratory requirements and personnel requirements for cytologists--HCFA. Final rule with comment period.
Fed Regist; 1994 Dec; 59(233):62606-9. PubMed ID: 10138980
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the ability of proficiency testing programs to determine intralaboratory performance. Peer group statistics vs clinical usefulness limits.
Ehrmeyer SS; Laessig RH
Arch Pathol Lab Med; 1988 Apr; 112(4):444-8. PubMed ID: 3355346
[TBL] [Abstract][Full Text] [Related]
15. Internal quality control of prothrombin time in primary care: comparing the use of patient split samples with lyophilised control materials.
Stavelin A; Petersen PH; Sølvik U; Sandberg S
Thromb Haemost; 2009 Sep; 102(3):593-600. PubMed ID: 19718482
[TBL] [Abstract][Full Text] [Related]
16. Interinstitutional comparison of bedside blood glucose monitoring program characteristics, accuracy performance, and quality control documentation: a College of American Pathologists Q-Probes study of bedside blood glucose monitoring performed in 226 small hospitals.
Novis DA; Jones BA
Arch Pathol Lab Med; 1998 Jun; 122(6):495-502. PubMed ID: 9625416
[TBL] [Abstract][Full Text] [Related]
17. [Analytical uncertainty--how wrong can a laboratory result be?].
Bolann BJ; Stølsnes B
Tidsskr Nor Laegeforen; 1999 Dec; 119(30):4472-5. PubMed ID: 10827487
[TBL] [Abstract][Full Text] [Related]
18. Matrix effects and accuracy assessment. Identifying matrix-sensitive methods from real-time proficiency testing data.
Lawson NS; Williams TL; Long T
Arch Pathol Lab Med; 1993 Apr; 117(4):401-11. PubMed ID: 8466404
[TBL] [Abstract][Full Text] [Related]
19. Development and operation of a quality assurance system for deviations from standard operating procedures in a clinical cell therapy laboratory.
McKenna D; Kadidlo D; Sumstad D; McCullough J
Cytotherapy; 2003; 5(4):314-22. PubMed ID: 12944238
[TBL] [Abstract][Full Text] [Related]
20. A multicentre evaluation of the Ektachem DT60-, Reflotron- and Seralyzer III systems.
Römer M; Haeckel R; Henco A; Vogt M; Thomas L; Keller HE; Appel W
Eur J Clin Chem Clin Biochem; 1992 Sep; 30(9):547-83. PubMed ID: 1457619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
